UK calls for access to new AMD therapies

Article

Quantitative analysis of the impact of neovascular age-related macular degeneration (AMD) on the UK population has led a team of researchers to call for urgent, early access to the new class of drug therapies for the disease.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Quan Dong Nguyen, MD, MSc, of the Byers Eye Institute at Stanford University School of Medicine, discusses his presentation on Stargardt disease at the American Academy of Ophthalmology meeting
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Related Content
An image of boxing gloves in a ring, hanging over an open flame. ©Image by Jennifer Toomey / MJH Life Sciences using AI

Up for debate: Clinicians take on hot topics at the Congress on Controversies in Ophthalmology

Hattie Hayes;Anat Loewenstein, MD;Baruch Kuppermann, MD, PhD
March 31st 2025
Article

This year, the COPHy meeting moves beyond retina, addressing uveitis, neuro-ophthalmology and glaucoma in Seville, Spain

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

A blue eye with a large splash of blue liquid coming out of it. Vitreoretinal surgery ILM dye stain concept. Image credit: ©Sergey Nivens – stock.adobe.com

Internal limiting membrane staining dye ILM-Blue from DORC (Zeiss) receives NMPA approval in China

Hattie Hayes
March 27th 2025
Article

The approval makes ILM-Blue the first DORC posterior dye product available in China, according to a press release from Zeiss

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

A person typing on a computer keyboard as icons representing documents and papers. Research paper publication concept image. Image credit: ©cherdchai – stock.adobe.com

Nanoscope Therapeutics publishes clinical results of MCO-010 findings for patients with retinitis pigmentosa

Martin David Harp
March 26th 2025
Article

The synthetic opsin was packaged into an optimised AAV2 gene therapy vector that targets human retinal bipolar cells.

The Moorfields Eye Hospital NHS Foundation Trust logo courtesy NHS Foundation Trust. Insitro logo courtesy Insitro. Lock and data point assets created with Canva.

Moorfields Eye Hospital INSIGHT research hub will collaborate with artificial intelligence development company Insitro

Hattie Hayes
March 24th 2025
Article

The partnership will use ocular imaging to build an AI foundation model and identify new genetic targets for degenerative diseases

© 2025 MJH Life Sciences

All rights reserved.